217 filings
Page 8 of 11
8-K
9cm7z nkk9j
6 Jan 05
AtheroGenics Receives Notice of Purported Class Action Lawsuit
12:00am
8-K
cbkdq
5 Jan 05
AtheroGenics Announces Proposed Offering of Convertible Notes
12:00am
8-K
2imtqc9ugl3n9p4fi9w
4 Jan 05
AtheroGenics Provides Update on AGI-1067 Clinical Program
12:00am
8-K
y4u cyrcxri
22 Dec 04
Entry into a Material Definitive Agreement
12:00am
8-K
ytts05w wpbvt
22 Nov 04
AtheroGenics Reports Positive Final Results from CART-2 Clinical Trial of AGI-1067
12:00am
8-K
gg3rik86i
21 Oct 04
AtheroGenics Reports Third Quarter 2004 Financial Results
12:00am
8-K
vuoqwvt92 0pc8u6ch
13 Oct 04
AtheroGenics Announces that OSCAR Phase II Study in Rheumatoid Arthritis Did Not Meet Primary Endpoint
12:00am
8-K
9gsg c63p08l79gpwu24
27 Sep 04
AtheroGenics Announces Positive Interim Results from CART-2 Study
12:00am
POS AM
xnmpwk8jnp2edvdhmxzo
1 Sep 04
Prospectus update (post-effective amendment)
12:00am
POS AM
9k9w x34g4
19 Aug 04
Prospectus update (post-effective amendment)
12:00am
8-K
25j4z 8nx2ejssyyyf
22 Jul 04
Financial statements and exhibits
12:00am
POS AM
9d6qj0l7z19o5x2 q4xy
22 Jun 04
Prospectus update (post-effective amendment)
12:00am
POS AM
atq6ww5rc
14 Jun 04
Prospectus update (post-effective amendment)
12:00am
POS AM
52n2l0etvptz4
25 May 04
Prospectus update (post-effective amendment)
12:00am
S-8
mrh 64p0pewbzgi2iou
28 Apr 04
Registration of securities for employees
12:00am
8-K
laimd ic4l0
22 Apr 04
Financial statements and exhibits
12:00am